Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
about
Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET ProteinsSilybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.The ASK1 Inhibitor Selonsertib in Patients with Nonalcoholic Steatohepatitis: A Randomized, Phase 2 Trial.Clinical relevance of liver histopathology and different histological classifications of NASH in adults.Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders
P2860
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
@en
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
@nl
type
label
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
@en
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
@nl
prefLabel
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
@en
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
@nl
P2860
P356
P1433
P1476
Nonalcoholic fatty liver disease: Fibrosis portends a worse prognosis.
@en
P2093
Dawn M Torres
Stephen A Harrison
P2860
P304
P356
10.1002/HEP.27680
P407
P577
2015-03-19T00:00:00Z